See more : Comet Industries Ltd. (CMU.V) Income Statement Analysis – Financial Results
Complete financial analysis of PT Jayamas Medica Industri Tbk (OMED.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Jayamas Medica Industri Tbk, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Akkhie Prakarn Public Company Limited (AKP.BK) Income Statement Analysis – Financial Results
- Kimbell Tiger Acquisition Corporation (TGR) Income Statement Analysis – Financial Results
- Modern Steels Limited (MDRNSTL.BO) Income Statement Analysis – Financial Results
- Tavernier Resources Limited (TAVERNIER.BO) Income Statement Analysis – Financial Results
- Admicom Oyj (ADMCM.HE) Income Statement Analysis – Financial Results
PT Jayamas Medica Industri Tbk (OMED.JK)
About PT Jayamas Medica Industri Tbk
PT Jayamas Medica Industri Tbk manufactures and sells medical devices and supplies under the OneMed brand in Indonesia, Asia, the United States of America, South America, and Africa. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising syringes, gauze, plaster bandage, masks, medical gloves, urine bag, foley cathether, alcoholic tissue, etc.; antiseptic and disinfectant liquids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, tensimeter, oxymeter, fingertip pulse etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, pediatric patient bed, and operation lamp, as well as other consumer medical products. It distributes and retails medical supplies and equipment through Medicom stores and online platforms. PT Jayamas Medica Industri Tbk was founded in 2000 and is headquartered in Sidoarjo, Indonesia. PT Jayamas Medica Industri Tbk operates as a subsidiary of Pt. Intisumber Hasilsempurna.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1,736.99B | 1,739.05B | 2,226.57B | 1,994.54B | 1,228.05B |
Cost of Revenue | 1,184.99B | 1,175.98B | 1,322.28B | 957.60B | 782.58B |
Gross Profit | 552.00B | 563.07B | 904.29B | 1,036.94B | 445.47B |
Gross Profit Ratio | 31.78% | 32.38% | 40.61% | 51.99% | 36.27% |
Research & Development | 0.00 | 0.00 | 0.00 | 715.10M | 514.70M |
General & Administrative | 38.73B | 31.23B | 18.97B | 28.13B | 72.86B |
Selling & Marketing | 65.02B | 53.03B | 42.95B | 59.58B | 72.89B |
SG&A | 103.75B | 84.26B | 61.92B | 87.72B | 149.96B |
Other Expenses | 145.68B | 3.76B | 799.10M | 2.45B | -3.33B |
Operating Expenses | 249.44B | 190.83B | 171.19B | 189.13B | -3.33B |
Cost & Expenses | 1,434.43B | 1,366.81B | 1,493.47B | 1,146.73B | -3.33B |
Interest Income | 43.52B | 14.37B | 16.91B | 14.95B | 10.16B |
Interest Expense | 19.41B | 20.65B | 21.71B | 9.01B | 531.56M |
Depreciation & Amortization | 25.81B | 22.94B | 17.29B | 3.21B | 13.61B |
EBITDA | 371.38B | 415.70B | 768.20B | 872.22B | 305.79B |
EBITDA Ratio | 21.38% | 23.90% | 34.51% | 43.70% | 0.27% |
Operating Income | 302.56B | 378.95B | 734.46B | 854.21B | 3.33B |
Operating Income Ratio | 17.42% | 21.79% | 32.99% | 42.83% | 0.27% |
Total Other Income/Expenses | 23.60B | -6.84B | -5.26B | 7.47B | 9.63B |
Income Before Tax | 326.16B | 372.11B | 729.20B | 860.00B | 302.29B |
Income Before Tax Ratio | 18.78% | 21.40% | 32.75% | 43.12% | 24.62% |
Income Tax Expense | 65.18B | 81.60B | 158.82B | 167.13B | 74.26B |
Net Income | 259.36B | 285.78B | 562.69B | 685.51B | 226.21B |
Net Income Ratio | 14.93% | 16.43% | 25.27% | 34.37% | 18.42% |
EPS | 9.59 | 10.56 | 20.80 | 25.33 | 4.43 |
EPS Diluted | 9.59 | 10.56 | 20.80 | 25.33 | 4.43 |
Weighted Avg Shares Out | 27.06B | 27.06B | 27.06B | 27.06B | 51.11B |
Weighted Avg Shares Out (Dil) | 27.06B | 27.06B | 27.06B | 27.06B | 51.11B |
Source: https://incomestatements.info
Category: Stock Reports